Urogen Pharma Ltd (URGN)

R&D Expenses

$61.26M

TTM · Period ending: · USD

URGN logo

URGN R&D Expenses

Latest reported$61.26M
URGN TTM R&D Expenses ($10.40M → $61.26M)
High-resolution chart · PNG

URGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
61,255,000
62,833,000
67,107,000
67,687,000
65,034,000
61,522,000
57,145,000
53,553,000
52,428,000
48,610,000
45,614,000
48,789,000
51,652,000
52,708,000
52,906,000
51,511,000
50,341,000
49,825,000
47,642,000
46,965,000
45,253,000
41,235,000
47,310,000
54,999,000
54,269,000
56,159,000
49,297,000
40,668,000
40,761,000
39,038,000
36,934,000
32,230,000
28,277,000
23,655,000
18,697,000
14,308,000
11,560,000
10,260,000
10,402,000
15,268,000
14,235,000
13,327,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.